Global Biomarkers Market Competition, Trade Overview And Market Forecast Till 2024
According to Data Bridge Market Research new Market report “Global Biomarkers Market, By Product Type (Consumables, Services, Softwares), By Technology (Efficacy, Safety, Validation), Application (Diagnostics, Drug Discovery, Personalized Medicine, Disease Risk Assessment), Indication (Cardiovascular, Immunological) By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Trends and Forecast to 2024”, has accounted to USD 31.4 billion in 2016, growing at a CAGR of 12.2% from 2017 to 2024, and is expected to reach USD 78.9 billion by 2024.
Request for free sample: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market
Biomarkers are substances or activities that serve as markers of a specific biological activity. Biomarkers are extensively used in research and diagnostic applications. In addition to this, they are also used in the development of new drug therapies through the discovery of new target drugs. Factors such as increasing healthcare expenditure, increase in R&D funding, rising utility of biomarkers for diagnostic purposes, growing number of CROs, low-cost for conducting clinical trials in developing countries, and new initiatives for biomarker research are driving the growth of the biomarkers market. On the other hand, high capital investments and high cost-to-benefit ratio; regulatory and reimbursement challenges; and high cost of testing, sample collection, and storage are the major factors restraining the growth of this market.
Market Segmentation: Global Biomarkers Market
• In this report, the Biomarkers Market is segmented on the basis of product type, technology, application, indication and geography.
• On the basis of technology, the biomarkers market is categorized into safety biomarkers, efficacy biomarkers, and validation biomarkers. In 2016, the safety biomarkers segment is expected to account for the largest share of the global biomarkers market. Safety biomarkers are primarily used in trial phases 1 and 2. They enable the identification of toxicity in candidate drug molecules. Increasing research and development activities in pharmaceutical sector, to identify and validate new candidate therapeutic products is driving the demand for this market segment.
• On the basis of applications, the Biomarkers Market is further segmented into diagnostics development, drug discovery and development, personalized medicine, disease-risk assessment, and other applications. In 2016, the diagnostics development segment is expected to account for the largest share of the global biomarkers market. Biomarkers play a significant role in the diagnosis of various diseases. Thus diagnostics development has major biomarker application compared to other applications due to increasing healthcare expenditure, which is improving access to new and high-quality diagnostics, and aiding growth of the diagnostics applications segment.
• On the basis of product type, the biomarkers market is segmented into consumables, services, and software. In 2016, the consumables product segment is expected to account for the largest share of the global biomarkers market. The large share of this segment can primarily be attributed to the increasing use of kit-based products for the testing of biomarkers and higher frequency of purchase of consumables as compared to other product segments.
• On the basis of indications, the biomarkers market is segmented into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases. In 2016, the cancer disease indication segment is expected to account for the largest share of the global biomarkers market. Cancer biomarkers are extensively used in diagnostics, asses cancer progression, prognosis, and to devise treatment plans. They are also used in companion diagnostics products. Increasing incidence of cancer is driving the growth of this segment of the biomarkers market.
Inquire before buying: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biomarkers-market
Geographical Segmentation: Global Biomarkers Market
Based on Geography the Global Biomarkers Market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as
• U.S.
• Canada,
• Mexico,
• Germany,
• France,
• U.K.,
• Belgium,
• Switzerland,
• Belgium,
• Turkey,
• Japan,
• China,
• Singapore,
• Brazil,
• India,
• Russia,
• South Africa
• and many others.
In 2016, North America is expected to dominate the market with a share of 35.6%, growing at a CAGR of 10.7% in the forecast period 2017 to 2024. The dominance of North America is owing to high incidence of cardiovascular diseases, coupled with favorable reimbursement scenarios and highest treatment success rate.
Competitive Landscape: Global Biomarkers Market
The major players in this market are turning to strategies such as mergers, acquisition and new product developments as major market strategies to penetrate the market. The biomarkers market is highly consolidated with few major companies having a large proportion of the market share. The key industry players in the global biomarkers market are QIAGEN N.V, PerkinElmer, Inc, Merck & Co, Inc. Bio-Rad Laboratories, Enzo Biochem, Inc., EKF Diagnostics Holdings, plc, Meso Scale Diagnostics, LLC, Singulex, Inc., Cisbio Bioassays, Biosims Technologies, and Signosis, Inc among other players.
Access Report: http://databridgemarketresearch.com/reports/global-sleep-apnea-devices-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Request for free sample: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market
Biomarkers are substances or activities that serve as markers of a specific biological activity. Biomarkers are extensively used in research and diagnostic applications. In addition to this, they are also used in the development of new drug therapies through the discovery of new target drugs. Factors such as increasing healthcare expenditure, increase in R&D funding, rising utility of biomarkers for diagnostic purposes, growing number of CROs, low-cost for conducting clinical trials in developing countries, and new initiatives for biomarker research are driving the growth of the biomarkers market. On the other hand, high capital investments and high cost-to-benefit ratio; regulatory and reimbursement challenges; and high cost of testing, sample collection, and storage are the major factors restraining the growth of this market.
Market Segmentation: Global Biomarkers Market
• In this report, the Biomarkers Market is segmented on the basis of product type, technology, application, indication and geography.
• On the basis of technology, the biomarkers market is categorized into safety biomarkers, efficacy biomarkers, and validation biomarkers. In 2016, the safety biomarkers segment is expected to account for the largest share of the global biomarkers market. Safety biomarkers are primarily used in trial phases 1 and 2. They enable the identification of toxicity in candidate drug molecules. Increasing research and development activities in pharmaceutical sector, to identify and validate new candidate therapeutic products is driving the demand for this market segment.
• On the basis of applications, the Biomarkers Market is further segmented into diagnostics development, drug discovery and development, personalized medicine, disease-risk assessment, and other applications. In 2016, the diagnostics development segment is expected to account for the largest share of the global biomarkers market. Biomarkers play a significant role in the diagnosis of various diseases. Thus diagnostics development has major biomarker application compared to other applications due to increasing healthcare expenditure, which is improving access to new and high-quality diagnostics, and aiding growth of the diagnostics applications segment.
• On the basis of product type, the biomarkers market is segmented into consumables, services, and software. In 2016, the consumables product segment is expected to account for the largest share of the global biomarkers market. The large share of this segment can primarily be attributed to the increasing use of kit-based products for the testing of biomarkers and higher frequency of purchase of consumables as compared to other product segments.
• On the basis of indications, the biomarkers market is segmented into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases. In 2016, the cancer disease indication segment is expected to account for the largest share of the global biomarkers market. Cancer biomarkers are extensively used in diagnostics, asses cancer progression, prognosis, and to devise treatment plans. They are also used in companion diagnostics products. Increasing incidence of cancer is driving the growth of this segment of the biomarkers market.
Inquire before buying: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biomarkers-market
Geographical Segmentation: Global Biomarkers Market
Based on Geography the Global Biomarkers Market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as
• U.S.
• Canada,
• Mexico,
• Germany,
• France,
• U.K.,
• Belgium,
• Switzerland,
• Belgium,
• Turkey,
• Japan,
• China,
• Singapore,
• Brazil,
• India,
• Russia,
• South Africa
• and many others.
In 2016, North America is expected to dominate the market with a share of 35.6%, growing at a CAGR of 10.7% in the forecast period 2017 to 2024. The dominance of North America is owing to high incidence of cardiovascular diseases, coupled with favorable reimbursement scenarios and highest treatment success rate.
Competitive Landscape: Global Biomarkers Market
The major players in this market are turning to strategies such as mergers, acquisition and new product developments as major market strategies to penetrate the market. The biomarkers market is highly consolidated with few major companies having a large proportion of the market share. The key industry players in the global biomarkers market are QIAGEN N.V, PerkinElmer, Inc, Merck & Co, Inc. Bio-Rad Laboratories, Enzo Biochem, Inc., EKF Diagnostics Holdings, plc, Meso Scale Diagnostics, LLC, Singulex, Inc., Cisbio Bioassays, Biosims Technologies, and Signosis, Inc among other players.
Access Report: http://databridgemarketresearch.com/reports/global-sleep-apnea-devices-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com